Immunotherapy in leprosy: a new approach.
An immunotherapeutic agent prepared from patient's own affected skin was tried in 30 leprosy cases. 53.6% cases of lepromatous and borderline lepromatous group showed lepromin conversion from lepromin negativity to positivity after 12 weeks of immunotherapy. The clinical and bacteriological improvement was also good. 88.1% cases of borderline tuberculoid also showed fair to good clinical recovery following 12 weeks of immunotherapy.
D006801:Humans; D007111:Immunity, Cellular; D007167:Immunotherapy; D007916:Lepromin / Q000276:immunology; D007918:Leprosy / Q000276:immunology / Q000628:therapy*
D007916:Lepromin